How Entrepreneurs Are Leading The Fight Against Fake Pharmaceuticals

Roger Bate | 03 May 2023 | Forbes

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe. Considering eighty percent of the ingredients in U.S. medicines come from overseas - mostly from China and India because their products are generally good and cheap - consumers are right to worry that insufficient oversight in foreign markets puts them at risk.

The AMFm and Medicine Diversion: Good intent enabling corrupt practices

Roger Bate, Julissa Milligan & Lorraine Mooney | 22 Feb 2024 | MalariaWorld Journal

Increased donated and subsidised medicines for malaria are saving countless lives in Africa, but there is probably increasing theft and diversion of those medicines. The impact of medicine diversion is unknown but potentially dangerous and may bolster criminal networks and increase medicine stock outs.

Time for a Fake Drugs Treaty

Roger Bate | 30 Jan 2024 | Africa Fighting Malaria

How vested interests and NGO politics are stalling much-needed international action against a deadly trade. The first international narcotics treaty, the Hague International Opium Convention was signed a century ago this week.

Fighting Malaria: Progress and Challenges

None | 05 Dec 2023 | Africa Fighting Malaria

On Monday, December 5th, AFM's Roger Bate testified before the Subcommittee on Africa, Global Health, and Human Rights on the increasing threat of antimalarial drug resistance in Africa.

Partners in Crime: National Theft of Global Fund Medicines

Roger Bate | 20 Apr 2023 | Africa Fighting Malaria

Millions of dollars of donated antimalarial drugs have been stolen, most often by staff of recipient government medical stores; this strengthens criminal gangs and undermines donor intent. The main culprit donor is the Global Fund to Fight AIDS, TB and Malaria, which worryingly is pushing ahead with further schemes that have the same inherent weaknesses, which may worsen the theft problem.

Measuring the AMFm

Richard Tren & Kimberly Hess | 04 Mar 2024 | The Lancet

In discussing measurement of the effectiveness of the Affordable Medicines Facility—malaria (AMFm), Olusoji Adeyi and Rifat Atun (Nov 27, p 1869)1 claim that "Expectations of attributable and rapid increases in measures of service delivery at the household level, which are neither new nor unique to AMFm, are inappropriate and unrealistic within the duration of the pilot studies."

Aid Agencies Turning a Blind Eye to Stolen Drugs

Roger Bate | 03 Mar 2024 | Economic Affairs

Aid agencies aim to do good; those providing medicines for fatal diseases save lives. Last year the US 'President's Malaria Initiative' (PMI) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) between them bought about 120 million treatments, mainly for sub-Saharan Africa.

Why and How to Make an International Crime of Medicine Counterfeiting

Amir Attaran, Roger Bate & Megan Kendall | 10 Feb 2024 | Journal of International Criminal Justice

The article explores why — when the counterfeiting of medicines is so prevalent, hard to detect and quietly dangerous or fatal — it remains totally unaddressed and therefore legal in international criminal law.

AFM Bulletin #5: Improving Assessments of Fake and Substandard Drugs in the Field

Roger Bate | 13 Jan 2024 | Africa Fighting Malaria

Substandard and counterfeit drugs can be lethal to patients and accelerate drug resistance across at-risk populations. This is a major problem for diseases like malaria with few high-quality treatments available.

Africa's Epidemic of Disappearing Medicine

Roger Bate | 11 Jan 2024 | Foreign Policy

The arrival of nearly $10 million worth of donated antimalarial drugs in the small West African country of Togo starting in 2005 should have been fantastic news for the hundreds of thousands of impoverished people who fall sick with malaria there each year.